Vera Therapeutics, Inc. (VERA) Tops Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.04 +7.15%
EPS Growth %: -27.8%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -27.8%
Financial Fact:
Engineering and software development: 322.64K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.52), $0.13 better than the analyst estimate of ($1.65).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HighPeak Energy mulls sale - Reuters
- FDA approves first gene therapy for Sanfilippo syndrome type A
- Wells Fargo expects Fed to hike rates one more time in 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
